Interview with Juan Craveri, President and CEO, Craveri
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Address: Arengreen 830 (C1405CYH), Buenos Aires,Argentina
Tel: +54 11 5453-4555
Web: http://www.craveri.com.ar/
One of the oldest pharmaceutical companies in Argentina, Craveri is a family-run company which is one of the forerunners in repositioning itself in order to best face the challenges of the pharmaceutical industry in the 21st century. Since 1996, the company has been involved with bioengineering, and was the first company in Argentina to help develop skin replacement treatments. Combined with their more traditional products, Craveri is well-positioned for growth and success in the years to come.
Diabetology, Phlebology, Neurology, Cardiovascular Disorders, Gastroenterology and Obesity
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Laboratorios Elea’s General Manager tells the story of the laboratories outstanding growth over the previous five years, the his firms upcoming launch of the first Argentinian developed biosimilar product. To…
The founder of Bomi Group’s affiliate in Argentina discusses the accomplishments of his firm thus far, and the challenges they have faced while trying to enter the very consolidated Argentinian…
Aegerion’s representative in Argentina discusses her efforts to raise awareness of Homozygous Familial Hypercholesteremia (HoFH), the rare disease targeted by her company’s ultra-orphan drug, and the remaining challenges of diagnosing…
Daniel Varde, Deloitte’s top consultant for the healthcare and life sciences sector in Latin America, discusses the interaction of global, Latin American, and Argentinian healthcare trends, and strategic techniques for…
“Argentina’s health system is in agony” In March 2002, amidst an economic crisis and national healthcare emergency the then Minister of Health Gines Gonzales Garcia declared “Argentina’s health system is…
Santiago Garcia Belmonte, president of Biosidus, discusses how global regulatory trends are driving change in the Argentinian biotech industry, as well the new direction his firm has taken over the…
The Executive Director of Argentina’s social security health provider, PAMI, discusses the institutions mission and evolution, as well as his hopes for the future of the Argentinian health system. What…
Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the current constraints limiting innovation in Argentina, and his company’s recent transition from…
Medtronic’s Regional Director for the South Cone shares with us the story of the company’s impressive success since the rebirth of their Argentinian affiliate in 2007, and indicates that Argentinian…
The national coordinator for Argentina’s ministry of health Plan Remediar discusses developing a professional management culture in the country’s public health centers, and the programs wider role in the public…
Dräger’s Sub Regional manager discusses the challenges of dealing with the fragmented and diverse Argentine healthcare sector, and some of the various strategies and approaches the firm uses to succeed…
The COO of Argentina’s largest logistics provider explains how the firm evolved into the preeminent player in the pharmaceutical logistics market, transporting roughly half of all pharmaceutical and medical device…
See our Cookie Privacy Policy Here
